Articles

Below is a list of links to publications by Dr. Rosenthal, as listed on Pubmed (website for National Library of Medicine). Some of his most popular articles are starred (*).

• Effects of transcendental meditation in veterans of Operation Enduring Freedom and Operation Iraqi Freedom with posttraumatic stress disorder: a pilot study.(*)
• Short exposure to light treatment improves depression scores in patients with seasonal affective disorder: A brief report.
• Phototherapy in subsyndromal seasonal affective disorder (S-SAD) and “diagnosed” controls. (*)
• Issues for DSM-V: seasonal affective disorder and seasonality.
• Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
• A missense variant (P10L) of the melanopsin (OPN4) gene in seasonal affective disorder.
• Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL.
• Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.
• Plasma leptin in men and women with seasonal affective disorder and in healthy matched controls.
• Effects of tryptophan depletion and catecholamine depletion on immune parameters in patients with seasonal affective disorder in remission with light therapy.
• Patients with seasonal affective disorder have lower odor detection thresholds than control subjects.
• Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder.
• A circadian signal of change of season in patients with seasonal affective disorder.
• Toward optimal health: the experts discuss seasonal affective disorder.
• Interview by JG Meisler.Band-specific electroencephalogram and brain cooling abnormalities during NREM sleep in patients with winter depression.Lithium: an orphan drug.
• Early response to light therapy partially predicts long-term antidepressant effects in patients with seasonal affective disorder.
• Pleiotropy of the serotonin transporter gene for seasonality and neuroticism.
• Self-reported sensitivity to chemical exposures in five clinical populations and healthy controls.
• Ultradian oscillations in cranial thermoregulation and electroencephalographic slow-wave activity during sleep are abnormal in humans with annual winter depression.
• Free thyroxine and thyroid-stimulating hormone levels in patients with seasonal affective disorder and matched controls.
• Summer and winter patterns of seasonality in Chinese college students: a replication.
• Monorhinal odor identification and depression scores in patients with seasonal affective disorder.
• Seasonal variations in mood and behavior among Chinese medical students.
• Seasonal mood change and neuroticism: the same construct?
• Seasonality associated with the serotonin transporter promoter repeat length polymorphism. (*)
• The role of genetic factors in the etiology of seasonal affective disorder and seasonality.
• Gender differences in glycosylated hemoglobin levels in seasonal affective disorder patients and controls.
• Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
• Hypomania interview guide (including hyperthymia): retrospective assessment version (HIGH-R).
• Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A.
• No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervosa, and alcoholism.
• The effects of seasons and light therapy on G protein levels in mononuclear leukocytes of patients with seasonal affective disorder.
• Greater improvement in summer than with light treatment in winter in patients with seasonal affective disorder.
• Serotonin 1A receptors, melatonin, and the proportional control thermostat in patients with winter depression.
• Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy.
• Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder.
• Lack of seasonal variation of symptoms in patients with chronic fatigue syndrome.
• Case series: pediatric seasonal affective disorder. A follow-up report.
• Effects of exogenous melatonin administration and withdrawal in five patients with rapid-cycling bipolar disorder.
• Light visor maintenance of light box response.
• Seasonal variation in core temperature regulation during sleep in patients with winter seasonal affective disorder.
• Seasonality and pituitary volume.
• A controlled trial of light therapy for the treatment of pediatric seasonal affective disorder.(*)
• A case of seasonal trichotillomania.
• A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization.
• Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms.
• Two naturally occurring amino acid substitutions of the 5-HT2A receptor: similar prevalence in patients with seasonal affective disorder and controls.
• Subsyndromal seasonal affective disorder in Antarctica.
• Winter seasonal affective disorder: a follow-up study of the first 59 patients of the National Institute of Mental Health Seasonal Studies Program. (*)
• Relationship between sleep and mood in patients with rapid-cycling bipolar disorder.
• Seasonal depression in patients with dissociative disorders.
• Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder.
• Cognitive performance in seasonal affective disorder: pattern recognition and the Stroop task.
• Seasonal changes in mood and behavior. The role of genetic factors.
• Effects of season on electro-oculographic ratio in winter seasonal affective disorder.
• Serotonin and thermoregulation. Physiologic and pharmacologic aspects of control revealed by intravenous m-CPP in normal human subjects.
• Olfactory function in winter seasonal affective disorder.
• Syndrome triad in children and adolescents.
• Prevalence of seasonal difficulties in mood and behavior among Japanese civil servants.
• The phototherapy light visor: more to it than meets the eye.
• Bimodal patterns of human melatonin secretion consistent with a two-oscillator model of regulation.
• Rates of seasonal affective disorder in children and adolescents.(*)
• Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls.
• Light therapy in patients with rapid cycling bipolar disorder: preliminary results.
• 1,25 (OH)2 vitamin D3 levels in seasonal affective disorder: effects of light.
• A controlled trial of cyanocobalamin (vitamin B12) in the treatment of winter seasonal affective disorder.
• Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorder.
• Multiple chemical sensitivity: lessons from seasonal affective disorder.
• A controlled trial of levodopa plus carbidopa in the treatment of winter seasonal affective disorder: a test of the dopamine hypothesis.
• Sleep in fall/winter seasonal affective disorder: effects of light and changing seasons.
• Behavioral responses to intravenous meta-chlorophenylpiperazine in patients with seasonal affective disorder and control subjects before and after phototherapy.
• Exposure to ambient light in patients with winter seasonal affective disorder.
• Findings from the Seasonal Pattern Assessment Questionnaire in patients with eating disorders and control subjects: effects of diagnosis and location.
• Effects of light on T-cells in HIV-infected subjects are not dependent on history of seasonal affective disorder.
• Diagnosis and treatment of seasonal affective disorder.
• Effects of phototherapy on electrooculographic ratio in winter seasonal affective disorder.
• Effects of bright light on mood in normal elderly women.
• Spontaneous eye blink rate in winter seasonal affective disorder.
• Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controls.
• Primary depressives with secondary alcoholism compared with alcoholics and depressives.
• A multicenter study of the light visor for seasonal affective disorder: no difference in efficacy found between two different intensities.
• Depressive symptoms and the self-reported use of alcohol, caffeine, and carbohydrates in normal volunteers and four groups of psychiatric outpatients.
• Biogenic amines in seasonal affective disorder: effects of light therapy.
• Retinopathy and bright light therapy.
• Predictors of response to phototherapy in seasonal affective disorder.
• Towards understanding the mechanism of action of light in seasonal affective disorder.
• Seasonal variation in obsessive-compulsive disorder: preliminary experience with light treatment.
• Multiple sclerosis and latitude: a new perspective on an old association.
• Contrasts between symptoms of summer depression and winter depression.(*)
• Seasonal variations in mood and behavior in the general population: a factor-analytic approach.
• Plasma melatonin as a measure of the human clock.
• Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications.
• Atenolol in premenstrual syndrome: a test of the melatonin hypothesis.
• Treatment of seasonal affective disorder with green light and red light.
• Core body temperature in patients with seasonal affective disorder and normal controls in summer and winter.
• Immunological correlates of seasonal fluctuations in mood and behavior and their relationship to phototherapy.
• Usage patterns of phototherapy in seasonal affective disorder.
• Adaptation to dim light in depressed patients with seasonal affective disorder.
• Exaggerated sensitivity to an organophosphate pesticide.
• Effect of daily variation in weather and sleep on seasonal affective disorder.
• Evaluation of seasonality in six clinical populations and two normal populations.
• Effects of bright light on resting metabolic rate in patients with seasonal affective disorder and control subjects.
• Effects of different wavelengths in seasonal affective disorder.
• Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome.(*)
• Exposure to ultraviolet B radiation during phototherapy.
• 2- versus 4-hour evening phototherapy of seasonal affective disorder.
• The effects of phototherapy in the general population.
• Prevalence of seasonal affective disorder at four latitudes. (*)
• Melatonin administration in insomnia.
• Effects of light treatment on core body temperature in seasonal affective disorder.
• Seasonal affective disorder and visual impairment: two case studies.
• Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland.
• Phototherapy in individuals with and without subsyndromal seasonal affective disorder.
• Seasonality and affective illness.
• Seasonal affective disorders and phototherapy. Report of a National Institute of Mental Health-sponsored workshop.
• Psychobiological effects of carbohydrate- and protein-rich meals in patients with seasonal affective disorder and normal controls.
• [Effects of light in depressive syndromes].
• Meal-related cholecystokinin secretion in eating and affective disorders.
• Phototherapy in subsyndromal seasonal affective disorder (S-SAD) and “diagnosed” controls.
• Affective disorders, light and melatonin.
• [Season-related forms of depression. I. Principles and clinical description of the syndrome].
• [Season-related forms of depression. II. Modification by phototherapy and biological results].
• Bulimia in obese individuals. Relationship to normal-weight bulimia.
• The timing and duration of sleep in partial sleep deprivation therapy of depression.
• Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients.
• Deficient nocturnal surge of TSH secretion during sleep and sleep deprivation in rapid-cycling bipolar illness.
• Atenolol in seasonal affective disorder: a test of the melatonin hypothesis.
• Personality as a dimension of summer and winter depression.
• Environmental and behavioral influences on affective illness.
• Neurobiology of seasonal affective disorder and phototherapy.
• Phototherapy for seasonal affective disorder.
• Seasonal affective disorder with summer depression and winter hypomania.
• The effect of melatonin on normal sleep.
• Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder.
• Morning versus midday phototherapy of seasonal affective disorder.
• No mood-altering effects found after treatment of normal subjects with bright light in the morning.
• Eye versus skin phototherapy of seasonal affective disorder.
• Treatment of a patient with seasonal premenstrual syndrome.
• Sleep reduction as a final common pathway in the genesis of mania.
• Seasonal affective disorder: a review of the syndrome and its public health implications.
• Biological effects of morning-plus-evening bright light treatment of seasonal affective disorder.
• Disturbances of appetite and weight regulation in seasonal affective disorder.
• A psychophysiological study of insomnia.
• Phototherapy of seasonal affective disorder. Time of day and suppression of melatonin are not critical for antidepressant effects.
• Phototherapy for seasonal affective disorder in Alaska.
• The dexamethasone suppression test in seasonal affective disorder.
• Psychiatric aspects of the relationship between eating and mood.
• Seasonal affective disorder in children and adolescents. (*)
• Premenstrual changes: a comparison of five populations.
• Seasonal affective disorder & light: past, present and future.
• Melatonin in seasonal affective disorder and phototherapy.
• Treatment of seasonal affective disorder with light in the evening.
• Antidepressant effects of sleep deprivation and phototherapy.
• Effects of melatonin on performance testing in patients with seasonal affective disorder.
• Antidepressant effects of sleep deprivation in bright and dim light.
• Sleep and circadian rhythms in affective patients isolated from external time cues.
• Potentiation of antidepressant medications by phase advance of the sleep-wake cycle.
• Antidepressant effects of light in seasonal affective disorder.
• Seasonal affective disorder and phototherapy.
• Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy.(*)
• Age at onset and number of psychotic symptoms in bipolar I and schizoaffective disorder.
• Social outcome compared in psychotic and nonpsychotic bipolar I patients.
• Seasonal cycling in a bipolar patient.
• Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle.
• Melatonin secretion as a neurobiological “marker” and effects of light in humans.
• The phenomenology of bipolar I manic-depressive illness.
• The role of the lithium ion in medicine.
• Manic-depressive patients may be supersensitive to light.
• Toward the validation of RDC schizoaffective disorder.
• Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
• ECT in a depressed patient with adult onset diabetes mellitus.
• Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder.